Osteoboost in the News
Catch up on the latest media coverage about Bone Health Technologies and the breakthrough Osteoboost belt for osteopenia treatment.
October 17, 2024 Bone Health and Wellness Series Bone and Joint Health National Action Week is October 12-18. World Osteoporosis Day is October 20. Experts joined us to talk about Bone Health, Osteoporosis, the Osteoboost product and Wellen… | |
September 30, 2024 The Osteoporosis Report Osteoboost is a new wearable vibration therapy device making waves in bone health circles. Osteoboost is the only FDA-cleared… | |
August 23, 2024 NIA Small Business Showcase: Bone Health Technologies Osteopenia, the precursor to osteoporosis, is a highly common skeletal condition with accelerated loss of bone mass and increased risk of bone fracture. If bone density loss is not mitigated… | |
July 25, 2024 Bone Health Technologies Acquires Wellen Bone Health Technologies (BHT), a leading medical technology innovator developing breakthrough non-pharmacological solutions to improve bone health and reduce fractures, today announced the company has acquired Wellen… | |
July 25, 2024 Bone Health Technologies Acquires Digital Health Startup Wellen to Advance Comprehensive Osteoporosis Care Bone Health Technologies (BHT), a company specialized in the development of non-pharmacological solutions to improve bone health and reduce fractures, has announced the acquisition of Wellen, | |
May 2024 Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment In a first for the treatment of osteopenia, the Osteoboost — a wearable device that delivers precise vibrations to the spine and hips — promises to offer a new form of therapy… | |
March 27, 2024 The future of female bone health: An interview with Laura Yecies Today, we feature Laura Yecies, CEO of Bone Health Technologies (BHT), who is shaking up, literally, the FemTech space with a non-pharmaceutical approach to strengthening bones in post-menopausal women… | |
March 4, 2024 Bone Health Technologies raises $5M as it readies for launch Bone Health Technologies (BHT) is a developer of a hardware device for improving bone health using vibrations, helping the 44 million Americans with osteopenia… | |
March 4, 2024 Bone Health Technologies Raises $5M to Launch Bone Density Wearable Bone Health Technologies (BHT), a health technology innovator developing breakthrough non-invasive solutions for bone health, today announced the company has raised a new $5 million funding round… | |
March 4, 2024 Bone Health Technologies Raises $5M to Advance Osteopenia Treatment Bone Health Technologies (BHT) has recently closed a $5 million funding round to enhance care for individuals with low bone density… | |
February 23, 2024 【CEOインタビュー】NASAの研究から着想、振動で骨密度を改善するウェアラブルデバイス「Osteoboost」 | |
February 6, 2024 FDA Clears First Non-drug Prescription Device for Women with Osteopenia FDA has cleared OsteoBoost, developed by Bone Health Technologies, the first vibration belt shown to reduce loss of bone strength and density in postmenopausal women with osteopenia…. | |
February 5, 2024 Morning Briefing – In The News The U.S. Food and Drug Administration (FDA) recently granted clearance for a vibration belt known as Osteoboost… | |
February 4, 2024 To fight bone loss, FDA approves vibration belt shown to help post-menopausal women Post-menopausal women may soon have a new weapon in the fight against bone loss. The U.S. Food and Drug Administration (FDA) recently granted clearance for a vibration belt known as Osteoboost… | |
February 3, 2024 Revolutionary Wearable Vibration Belt Receives Nod for Osteopenia Relief in Post-menopausal Women THE U.S. FOOD AND DRUG ADMINISTRATION HAS GIVEN the green light to a special belt that uses vibrations as a treatment for post-menopausal women dealing with osteopenia… | |
January 25, 2024 NEW Osteoboost: Game-Changer for Bone Health! Hi everyone, Dr. Susan Brown here from Costa Rica with exciting news! The FDA has approved Osteoboost, a non-pharmacological treatment for osteopenia… | |
January 25, 2024 FDA Approves Vibrating Belt to Help Women With Osteopenia Keep Bone Strength The US Food and Drug Administration (FDA) has approved a wearable belt device for postmenopausal women with osteopenia, the precursor to osteoporosis, according to the company’s manufacturer, Bone Health Technologies… | |
January 25, 2024 This ‘Osteoboost’ Belt Could Mean Big Things For Bone Health As women age, preventing bone density loss becomes increasingly important, given that it has a direct correlation with fractures and a decreased quality of life. Previously, the treatment options for osteopenia… | |
January 24, 2024 Top in endocrinology: FDA OKs vibration belt for osteopenia The FDA cleared a wearable vibration belt to treat postmenopausal women with osteopenia, according to an industry press release… | |
January 23, 2024 FDA clearance of first prescription wearable to treat low bone density The FDA has granted clearance to a wearable belt that delivers targeted vibrations to the spine and hips as the first non-drug prescription medical device to treat low bone density… | |
January 22, 2024 FDA clears vibrating belt to boost brittle bones in women facing osteoporosis The FDA has granted a clearance to its first prescription medical device to help treat low bone density, with a wearable vibrating belt designed for postmenopausal women… | |
January 22, 2024 Vibrating belt that treats low bone density gets FDA approval The device is the first of its kind to provide a medication-free treatment option for post-menopausal women that have weakened bones… | |
January 19, 2024 FDA clearance strengthens Osteoboost’s position as first osteopenia device In a boon to older women worldwide, Bone Health Technologies Inc. received U.S. FDA clearance for its Osteoboost device, which reduces loss of bone strength in postmenopausal women… | |
January 18, 2024 FDA Clears Osteoboost by Bone Health Technologies to Address Osteopenia in Women Bone Health Technologies, a company at the forefront of bone health solutions, recently announced the FDA clearance of Osteoboost, the first device-based, non-pharmacological prescription treatment… | |
January 18, 2024 FDA Clears Osteoboost: A Revolutionary Wearable Device for Osteopenia Treatment The U.S. Food and Drug Administration (FDA) has granted clearance for a pioneering device called Osteoboost… | |
January 18, 2024 Breaking News: Bone Health Technologies’ Osteoboost Cleared by FDA The U.S. Food and Drug Administration (FDA) has granted clearance for Bone Health Technologies’ Osteoboost, a non-pharmacological device-based prescription treatment for postmenopausal women diagnosed with osteopenia (low bone density)… | |
January 18, 2024 Prescription Belt Device Gets FDA Clearance for Postmenopausal Women With Osteopenia The Food and Drug Administration (FDA) has cleared Osteoboost™, a prescription device for the treatment of postmenopausal women diagnosed with osteopenia… | |
December 6, 2023 Bone Health Technologies Earns 4th Patent for Osteoboost Device Bone Health Technologies (BHT), an innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization of the Osteoboost device, which has been shown in clinical trials to reduce the loss of bone mass in post-menopausal women… | |
June 20, 2023 Bone Health Technologies Presents Promising Clinical Trial Data of Wearable Treatment for Osteopenia in Post-Menopausal Women San Francisco-based Bone Health Technologies (BHT) has presented pivotal trial data for its novel treatment Osteoboost at the renowned endocrinology conference, Endo 2023… | |
November 30, 2022 Top-line results: Vibration belt slows bone strength decline among adults with osteopenia A belt device that mechanically stimulates bones through vibration slowed the decline in bone strength among adults with osteopenia, according to top-line results announced in an industry press release… | |
October 11, 2022 NASA Research Behind New Osteoporosis Work A bone health study based on NASA research is underway thanks to San Francisco-based Bone Health Technologies, Inc., the San Francisco VA Health Care System, and the University of California, San Francisco (UCSF)… | |
November 10, 2021 $2.7M NIH Grant to Bone Health Technologies San Francisco-based Bone Health Technologies, makers of OsteoBoost, has been awarded $2.7 million in a Commercialization Readiness Pilot grant as part of the Small Business Innovation Research Program… | |
June 23, 2021 Osteoporosis Company Lands Second Patent The United States Patent and Trademark Office has granted San Francisco, California-based Bone Health Technologies its second patent for its OsteoBoost vibration belt… | |
May 17, 2021 This Medtech Company Invented A Solution To Treat Bone Health Conditions Affecting 54 Million Americans And Costing The Healthcare System $19 Billion Annually There is a silent osteoporosis epidemic globally. Currently, it has been estimated that more than 200 million people are suffering from osteoporosis… | |
May 14, 2021 How a NASA-inspired belt could treat low bone density using vibration to prevent osteoporosis The musculoskeletal system is designed to be resilient against the physical trials and tribulations of our day-to-day lives, but in order to do this job well we have to maintain it by challenging it regularly with weight-bearing exercises… | |
February 22, 2021 Bone-Stimulating Device Uses NASA-Developed Tech to Help Prevent Osteoporosis After bone density peaks, typically when people reach their 30s, most experience a slow decline from bone cells dying and being resorbed without being entirely replaced, said Laura Yecies, CEO of Bone Health Technologies… | |
December 15, 2020 Vibrating Belt Gets FDA ‘Breakthrough Device’ Designation for Osteoporosis The U.S. Food and Drug Administration has given “Breakthrough Device” designation to a vibrating belt that lowers the risk of bone fractures caused by osteoporosis… |